Frequency of low BMD and associated risk factors in patients with inflammatory bowel disease

Chinmoy Saha; M. Anwarul Kabir; Chanchal Kumar Ghosh; Ishita Saha; M. Khademul Islam; M. Fazlul Karim Chowdhury; Nimai Das; Tasmia Tanjum

doi:10.18203/2320-6012.ijrms20244089

Authors

Chinmoy Saha Department of Gastroenterology, Sheikh Russel National Gastroliver Institute & Hospital, Dhaka, Bangladesh
M. Anwarul Kabir Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Chanchal Kumar Ghosh Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Ishita Saha General of Health Services, Dhaka, Bangladesh
M. Khademul Islam Department of Medicine, Upazila Health Complex, Fulbaria, Mymensingh, Bangladesh
M. Fazlul Karim Chowdhury Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Nimai Das Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Tasmia Tanjum Department of Radiology & Imaging, Sir Salimullah Medical College Mitford Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20244089

Keywords:

Inflammatory bowel disease, Low BMD, Osteopenia, Osteoporosis, Risk factors

Abstract

Background: Low bone mineral density (BMD) is a known complication of inflammatory bowel disease (IBD), with several factors contributing to its occurrence. This study aims to assess the frequency of BMD and identify associated risk factors in patients with IBD. The aim of this study was to determine the frequency of low BMD and identify associated risk factors in patients with inflammatory bowel disease (IBD).

Methods: This cross-sectional study included 90 patients with established inflammatory bowel disease (IBD) at the Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from June 2019 to September 2020. Patients aged 18 years and older, currently on IBD medication, were enrolled. Data on BMD, disease characteristics, and demographic factors were collected and analyzed using SPSS version 23.0.

Results: Among 90 IBD patients (mean age 31.8 years, 74.4% male, 35.6% with Crohn's), 40% were smokers. BMD results showed 34.4% normal, 40% osteopenia, and 25.6% osteoporosis. Low BMD was linked to lower BMI (20.25kg/m²) and vitamin D levels (17.45ng/ml), with regression analysis confirming vitamin D deficiency as the only independent risk factor.

Conclusions: Our study underscores the high prevalence of osteopenia and osteoporosis in Bangladeshi IBD patients, highlighting the critical need for regular monitoring and intervention focused on modifiable risk factors like BMI and vitamin D to safeguard bone health.

Metrics

Metrics Loading ...

References

Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. The Lancet. 2007;12(9573):1627-40.

Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. The Am J Med. 2009;1;122(7):599-604.

Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Int Medicine. 2000;21;133(10):795-9.

Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. The Am J Clin Nutr. 1991;1(3):548-52.

Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;1;57(5):684-94.

Lacativa PG, Farias ML. Osteoporosis and inflammation. Arquivos Brasileiros de Endocrinologia & Metabologia. 2010;54:123-32.

Kim HJ. New understanding of glucocorticoid action in bone cells. BMB reports. 2010;43(8):524-9.

Andreassen H, Hylander E, Rix M. Gender, age and body weight are the major predictive factors for bone mineral density in Crohn’s disease: a case-control cross-sectional study of 113 patients. The American journal of gastroenterology. 1999;1;94(3):824-8.

Silvennoinen JA, Lehtola JK, Niemelä SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scandinavian journal of gastroenterology. 1996;1;31(4):367-71.

Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis. Journal of internal medicine. 2000;247(1):63-70.

Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American Journal of Gastroenterology (Springer Nature). 1997;1;92(2).

Penman ID, Lees CW. Alimentary tract and pancreatic disease. Davidson’s Principles & Practice of Medicine. 2014:837-920.

Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ulcerative colitis: diagnosis and treatment. American family physician. 2007;1;76(9):1323-30.

Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Official journal of the American College of Gastroenterology| ACG. 2004;1(7):1371-85.

Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clinical Gastroenterology and Hepatology. 2008;6(1):41-5.

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. ACG. 2001;96(4):1116-22.

Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population‐based study (the IBSEN study). Rheumatol. 2001;40(11):1256-61.

Sands BE, Siegel CA. Crohn’s Disease. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 10th ed. Philadelphia: Saunders. 2016: 1990-2022.

Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut. 1997;40(3):313-9.

Ezzat Y, Hamdy K. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. International J Rheum Dis. 2010;13(3):259-65.

Khadgawat R, Makharia GK, Puri K. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol. 2008;1;27(3):103-6.

Bundela RP, Ashdhir P, Narayan KS, Jain M, Pokharna RK, Nijhawan S. Prevalence and risk factors for low bone mineral density in ulcerative colitis. Ind J Gastroenterol 2017;36:193-6.

Even Dar R, Mazor Y, Karban A, Ish-Shalom S, Segal E. Risk factors for low bone density in inflammatory bowel disease: use of glucocorticoids, low body mass index and smoking. Dig Dis. 2019;21(4):284-90.

Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Digestive Dis and Sci. 2014;59:1878-84.

Ismail MH, Al-Elq AH, Al-Jarodi ME, Azzam NA, Aljebreen AM, Al-Momen SA, et al. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease. Saudi J Gastroenterol. 2012;18(3):201-7.

Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, et al. Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorec Dis. 2006;21:758-66.

Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A, Łykowska-Szuber L, Stawczyk-Eder K, Waszak K, et al. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region. Polish Archives of Int Med. 2018;11(7):447-54.